Skip to main content
. 2022 Mar 21;15(1):59–69. doi: 10.4103/ijoy.ijoy_160_21

Table 4.

Comparison between control group and intervention group parameters at day 28

Parameters Control group (n=38) Intervention group (n=34) P (Cohen’s d effect size)
IOP-r (mm hg) 16.3 (13.85-18.55) 15.15 (13-17.08) 0.114
Δt1-t3 0 (0-+1.0) −1.0 (−2.0-0) 0.0002* (0.7961)
IOP-l (mm hg) 16.43±4.08 15.4±3.12 0.234
Δt1-t3 0.0 (−2.00-+1.0) −0.50+2.15 0.040* (0.2158)
GQL-15 31 (19.75-40) 30 (22-41.5) 0.699
Average BREF 57.63 (51.13-69.75) 61 (58-75) 0.260
Cortisol 226.3 (190.9-372.2) 226.9 (182.3-358.6) 0.532
Beta endorphin 117.8 (73.71-307.4) 122 (158.87-355.8) 0.769
HR bpm 79.87±11.68 75.76±9.32 0.106
SBP (mm hg) 123.3±13.27 127.1±14.69 0.259
DBP (mm hg) 77.95±10.04 79.5±8.33 0.480
FBG (mg/dl) 97.04 (89.09-111.2) 92.90 (84.72-102.7) 0.118
Weight (kg) 64.22±13.42 68.22±12.36 0.194
BMI (kg/sqm) 25.13 (22.87-27.17) 26.92 (23.19-29.11) 0.170

*P value found <0.05. Unpaired t-test results are presented as mean±SD and Mann-Whitney U test results are presented as median (Q1-Q3). Δt represents gain score i.e., the change in the value in comparison to the baseline value at Day1. SD=Standard deviation, IOP=Intraocular pressure, IOP-r=IOP of right, IOP-l=IOP of left, GQL-15=Glaucoma quality of life-15, HR=Heart rate, BP=Blood pressure, SBP=Systolic BP, DBP=Diastolic BP, BMI=Body mass index, FBG=Fasting plasma glucose, Q1=First quartile, Q3=Third quartile